Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
that is why I dont buy. no real volume means potential danger.
me too. volume increase would be most encouraging.
I like the chart set up on FNNZF moving toward the Canadian Legal event.
could be. The up open got sold off pretty quick on low volume/support.
The accumulation/distribution line in the chart looks like there is a dilution, are they selling little by little ???
Nice open here today!
Investment Considerations
Focused on California, the largest legal cannabis market in North America
Operates an attractive royalty model that is beneficial for operators and the company
Established partnerships with best-in-class operating entities
Extensive network provides access to top-tier projects and operators
Executive leadership team with 40+ years of combined experience in fund raising, capital management, corporate development, merchant and commercial banking
Digging in a bit.
Like the ...
Share price
Outstanding share number
Chart
Have not researched yet.
securing my position first, and then reminding you.
So I like the Royalty Model
they capitalize weed companies and then take a cut of the profits.
is it real?
I looked at these guy a while back and then completely forgot about them. Yesterday one of my "building mo" scans picked them up again.
we have to look at the companies they're funding to see if there are or will be any profits to get royalties from. I thought there investments to date looked at least interesting.
https://fincannacapital.com/royalty-portfolio/investment-portfolio-summary/
The fins say they have some $ coming in from loan interest, but I'm not sure if they're seeing revenue royalties yet.
The last form 7
https://webfiles.thecse.com/2018-07.pdf?zF2m_cTjWR1HgT7VSq0WGTXui6n86i8i
annual report:
https://webfiles.thecse.com/investorx/CALI/1808281651284106.pdf?gMeE.pzPlgtHIlvI3eOiSRjplsd.9lXh
MD&A:
https://webfiles.thecse.com/investorx/CALI/1808281653177622.pdf?j7Np9mRPdkZVdLQeVdCUcL20NG3RijTD
Last news (bod appointment):
https://webfiles.thecse.com/investorx/CALI/1808300457019882.pdf?OcXiCpO7iTUStvdA2z2L9q4LyyI5eAWp
As a chart play they are a buy imo. If not immediately, then as good entry points emerge.
As a long investment, I need to find out more about the underlying companies.
What have you found out about them?
Interesting, I am the only MOD and missed the chart.
Why were you holding out?
SHARES OUT
98,289,734
FNNZF - more revs just around the corner
buybuybuy
Sessions... You're Fired...
"The idea of having a new attorney general in the first term of President Trump's administration, I think is very likely," Sen. Graham says as AG Sessions faces mounting criticism from Pres. Trump. https://t.co/WTHXtU9FFt pic.twitter.com/IuHxNtEOWL
— MSNBC (@MSNBC) August 23, 2018
President Trump Likely to Replace Jeff Sessions
FinCanna Advances Second Tranche of Capital to ezGreen Compliance to Drive Continued Growth https://globenewswire.com/news-release/2018/08/08/1548660/0/en/FinCanna-Advances-Second-Tranche-of-Capital-to-ezGreen-Compliance-to-Drive-Continued-Growth.html
Cultivation Technologies, Inc. Reaches $1 Million in Cumulative Revenue Since Beginning Commercial Operations in January 2018
June 7, 2018
As an innovator in the emerging cannabis industry in California, Cultivation Technologies, Inc. ("CTI") - a leading manufacturer and distributor of licensed cannabis in California - announced today that it has reached $1 million in cumulative revenue since it started commercial operations earlier this year.
Through its subsidiaries Coachella Manufacturing and Coachella Distributors, CTI provides "Extraction-as-a-Service" or "Contract Manufacturing" to brands, cultivators, manufacturers, and distributors who require licensed Butane Hash Oil ("BHO") processing for their biomass or manufacturing services for various products.
With divisions that fulfill the varying levels of procurement of cannabis products, including distribution to retail dispensaries, CTI remains at the forefront of this developing industry - including meeting the complex standards required to be fully-licensed within the state.
Earlier this week, CTI made news with the expansion of its Coachella™ Premium brand of cannabis concentrates and vape cartridges in California dispensaries. The Coachella™ Premium line of products features all the major concentrate types - including diamonds, sauce, shatter, batter, and sugar - with an ongoing list of strains.
The company was also instrumental in sponsoring state legislation AB2679, which sets safety standards and institutional best practices for cannabis extraction using solvents.
"We're quite encouraged about the revenue growth CTI is experiencing in just a few short months since launching operations," said Miguel Motta, President & CEO of Cultivation Technologies, Inc. "We've learned a lot about the market and expect to build upon our initial success in 2018 and beyond."
ABOUT CULTIVATION TECHNOLOGIES, INC.
Cultivation Technologies, Inc. provides infrastructure, manufacturing, extraction, distribution, technology, and branding to the legal medical cannabis industry. The company owns 6-acres in Coachella, California, which is entitled for a 111,500+ square foot facility featuring cultivation centers, manufacturing facilities, a testing lab, a distribution hub featuring transportation, and a centralized processing center. For more information, visit www.CultivationTech.com. The Company acquired temporary licenses for "Type 7" manufacturing and distribution from the State of California in January 2018.
Double bottom.
found this https://www.newcannabisventures.com/questionable-california-cannabis-startup-touts-60mm-in-revenue-within-first-year/
CEO Beck’s LinkedIn profile suggests that he joined the company earlier this year. The corporate website describes him as a founding shareholder of MJIC and having involvement with a publicly traded vaporizer company. Beck founded the Marijuana Index, which is owned by MJIC, and was apparently involved very early in Vape Holdings (OTC: VAPE), though this is not disclosed in any SEC filings. VAPE did a reverse-merger in 2013, soared in early 2014 and has lost nearly 100% of its value.
Most interesting about Beck’s background is his apparent involvement in a penny stock pump and dump scheme that resulted in a settlement that included disgorgement as well as a five-year injunction that ended shortly before Beck joined CTI. Beck was prohibited from “directly or indirectly soliciting investors to purchase or sell securities.” The SEC complaint alleges that Beck was managing director of Del Mar Corporate Communications, which oversaw a “cold call telemarketing campaign of materially false or misleading information” on behalf of Pax Clean Energy, which was suspended from trading by the SEC in 2009.
CFN Exclusive Interview with FinCanna CEO Andriyko Herchak
By GlobeNewswire, June 14, 2018
SEATTLE, June 14, 2018 (GLOBE NEWSWIRE) -- CFN Media recently sat down with FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF) CEO Andriyko Herchak to discuss the company's royalty investment model, its accomplishments to date, and its strategy going forward.
CFN: Thank you for your time today Mr. Herchak, and congratulations on your recent news. Before we discuss the news, please give us an overview of FinCanna Capital and its royalty model.
Andriyko Herchak: You are welcome, it's a pleasure to speak with you today. At FinCanna Capital we are building a diversified portfolio of royalty based income by investing in top tier companies in the United States medical cannabis industry, with a focus on California. What is a royalty? Basically, we invest capital in a company and in exchange we receive a percentage of its revenue going forward. It has been a very successful model in other industries and we believe now is the perfect time for this royalty model in the US cannabis space and particularly in California. Our royalty model allows operators and business owners to preserve their ownership stake, not diluting themselves as they would with typical equity financing.
CFN: Why do you think the royalty model makes sense for cannabis companies today, particularly in the United States?
AH: In California right now, basically every company is a startup or running a startup, many with no history of revenues. If those companies are trying to raise money, equity financing can be massively dilutive, in large part due to the lack of a track record of revenue production. Our model does not look back, but rather forward. Our investment approach allows companies to preserve equity while providing cash to grow their business.
Additionally, cannabis is still federally illegal, which is a major contributing factor for the shortage of capital for cannabis companies across the US. Banks and federally regulated institutions are largely on the sidelines, so debt financing is difficult to find. Equity financing, as I mentioned earlier, often comes with unfavorable terms for the company. So our royalty model fills a void in the market for companies needing capital while operating in the US cannabis space.
CFN: Which companies have you invested in to this point, and why?
AH: Our royalty portfolio is currently comprised of three investments. We invest in management and the underlying business, that's really our focus and the top criteria for us. The first company we've invested in is, Cultivation Technologies Inc., ("CTI"). They have an exceptional management team that has proven itself in other industries. The CEO is a former executive of one of the largest agricultural companies in the world. The company is developing a large medical cannabis campus in Coachella, California. The two main revenue drivers will be cultivation and extraction. They were one of the early movers in California and we've been alongside them from the beginning. Its a large scale opportunity and we look forward to great things as the planned cannabis campus project moves forward.
Our second investment is with Green Compliance, a company that offers a HIPAA compliant software solution for cannabis companies. The industry is riddled with problems around data security. To our knowledge, none of the other point of sale (POS) software solutions out there were designed to protect client/patient data at the level to be delivered by Green Compliance and as required under HIPAA. The company offers a POS system that has been proven in the pharmaceutical industry over the last 17 years and is now being repurposed for the cannabis sector. The Green Compliance has the flexibility to integrate as a plug-in with any existing seed-to-sale software or it can operate as a stand-alone point-of-sale system.
Our third investment is in Gram Co, based in Oakland California. The company's business is to extract high quality cannabis distillate for major brands in California. The Gram Co team are seasoned extractors, highly experienced, and very well connected in the industry. We expect the company to be fully operational later this year.
CFN: Excellent. FinCanna recently announced that your portfolio company, CTI, has secured distribution across California and commenced sales of its Coachella Premium Cannabis product line. Why is this significant for your company?
AH: First of all, we have a 50% profit interest in CTI's extraction facility. CTI is developing its own premium brand in a market where having your own brand offers the highest revenues available in the vertical. While CTI only commenced operations in late January this year, they have already managed to secure distribution with 10 of the largest dispensaries in California. With California representing the 6th largest economy in the world, we expect a large financial win as the company progresses.
CFN: CTI has infrastructure that really sets the company apart. Can you tell us more about Coachella Manufacturing?
AH: CTI received one of the first solvent extraction permits in California and is one of the first companies to legally extract in the state. CTI has a clear first mover advantage in what amounts to a race to market across California. Their facility includes a state of the art, licensed lab with the latest in cold storage, extraction, and distillation technologies designed to produce premium and unique products for an increasingly discerning marketplace.
CFN: Is California going to be a major focus for FinCanna going forward?
AH: Absolutely. Our ticker symbol is CALI, and that was intentional. California was the first jurisdiction to legalize medical cannabis in North America, thirty years ago. It's by far the largest legal cannabis market in North America. The new laws that came into effect in the state this year are serving to both open the market but also demands a higher level of regulatory compliance for market participants as the green rush ramps up. There is a great race to market as entrepreneurs see tremendous, once in a generation opportunity. There are a lot of great companies out there that, due to restrictive federal regulations, are not able to obtain adequate financing. So we have this incredible opportunity to pair our attractive royalty financing with great operators to grow top tier businesses.
CFN: How does FinCanna build upon the success you've had to this point?
AH: It all comes down to the companies we invest in. We invest in companies we believe have the best opportunity to become leaders in their respective verticals. For companies we've invested in to date, we expect them to grow in size and reach without any further investment on our part. We will apply the same methodology to future investments by choosing the top companies that will become leaders in their own verticals. As those companies grow, our royalties grow accordingly. Success comes down to financing the right companies, with the right management, in the right sectors. We think we are well on our way with the companies we've financed to date and look forward to expanding our portfolio as opportunities present themselves.
For more information and to read the company's statement regarding potential risks visit www.fincannacapital.com
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.
Coverage Initiated for FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) via NetworkNewsWire
By GlobeNewswire, June 28, 2018
NEW YORK, June 28, 2018 (GLOBE NEWSWIRE) -- FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), a royalty company for the U.S. licensed medical cannabis industry, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").
FinCanna Capital is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.
The company's "whole capital" solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.
NNW is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. NNW's strategies help public and private organizations find their voice and build market visibility. As part of the Client-Partner relationship with FinCanna Capital, NNW will leverage its investor-based distribution network of over 5,000 key syndication outlets, various newsletters, social media channels, blogs, and other outreach tools to generate greater brand awareness for the company.
"FinCanna Capital is focused on driving growth and partnerships with vibrant businesses in the world's largest market for legal cannabis," states Sherri Franklin, Director of Client Solutions for NNW. "We look forward to assisting the company with a dynamic corporate communications campaign as it pursues opportunities in rapidly growing market verticals."
About FinCanna Capital Corp.
FinCanna provides financing to top-tier companies in the licensed medical cannabis industry in exchange for a royalty on revenues. FinCanna, led by a team of finance and industry experts, is building its diversified portfolio of royalty investments in scalable, best-in-class projects and companies in U.S. legal states, with a focus on California. For additional information visit www.FinCannaCapital.com
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets, (3) enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.NetworkNewsWire.com.
FinCanna Executes & Increases Royalty Payments Under Agreement with Refined Resin Technologies Inc. a California Based Cannabis and Extraction Company
By GlobeNewswire, July 10, 2018
New Structure Increases Royalty Payments to 11.75% of First US$160 Million of Annual Revenues
VANCOUVER, British Columbia, July 10, 2018 (GLOBE NEWSWIRE) -- FinCanna Capital Corp. ("FinCanna") (CSE:CALI) (OTCQB:FNNZF) a royalty company for the U.S. licensed medical cannabis industry, has executed an Expanded Royalty Agreement with Refined Resin Technologies Inc.("Refined Resin") formerly known as Gram Co Holdings LLC, of Oakland, California. Refined Resin is a cannabinoid research and refinery company that provides B2B and B2C products and services to licensed dispensaries and distributors in the medical cannabis supply chain.
FinCanna will fund US$3 million in tranches to complete the original Royalty Agreement transaction that was previously announced under a binding term sheet in February 2018. In return, FinCanna will receive a tiered corporate royalty, ranging from 14% to 5.0% of Refined Resin's annual revenues, based upon agreed upon benchmarks.
Concurrently, FinCanna has also agreed to acquire an Additional Royalty for the purchase price of US$1.795 million, payment that will be comprised of US$500,000 cash and the remainder paid in common shares of FinCanna. The Additional Royalty provides FinCanna the right to receive a further royalty payment of 2% of Refined Resin's revenues. Refined Resin has the option to repurchase the Additional Royalty subject to certain terms.
With the inclusion of the 2% additional royalty consideration, the tiered royalty payments to FinCanna now range from 16% to 7.0% based on agreed upon benchmarks, with the combined royalty rate to FinCanna totaling 11.75% on the first US$160 million of annual revenues payable in perpetuity subject to certain buy-back options.
The additional payment will allow Refined Resin to increase production volumes to take advantage of strong market demand that in turn will benefit FinCanna through accelerating speed to market and advancing the royalty payment schedule.
"We are very pleased to close this transaction with Refined Resin Technologies. It's an exciting opportunity for us on a number of levels. The Refined Resin team is highly skilled in the production and management of a sophisticated extraction facility," said Andriyko Herchak, President and CEO of FinCanna Capital. "Additionally, the team has very deep connections in the distribution and retail markets and are themselves very effective brand developers and marketers. Moreover, the potential capacity of the facility, and its ability to produce high value-add products bode well for the financial future of the enterprise and commensurately, outstanding value for FinCanna shareholders."
Refined Resin has leased a facility in Oakland, California in which they are retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating by the end of 2018. Refined Resin's principals have extensive experience in extraction, manufacturing and business operations and intend to be premier producers of bulk quantities of THC distillate and various high value concentrates produced via hydrocarbon-based solvent extraction.
Refined Resin also plans to provide white-labeling services to licensed brands and infused product manufacturers who do not have direct access to compliant production facilities. Brands and manufacturers who work in conjunction with Refined Resin will also be able to utilize in-house distribution and marketing expertise as part of their value add service offering.
The Royalty to FinCanna begins to accrue immediately upon disbursement of the initial advance payment. Refined Resin's Annual Revenues, for purposes of calculating the FinCanna royalty, are gross revenues less any sales returns calculated in accordance with GAAP. All funds advanced in the transaction are allocated for the retrofitting and development of the Refined Resin facility in Oakland and associated designated expenses.
About Refined Resin Technologies Inc.
Refined Resin Technologies, based in Oakland, California, is a cannabinoid research and refinement company focussed on the medical cannabis industry to provide B2B and B2C products and services to licensed dispensaries, infused product manufacturers and numerous others in the medical cannabis supply chain.
About FinCanna Capital Corp.
FinCanna provides financing to top-tier companies in the licensed medical cannabis industry in exchange for a royalty on revenues. FinCanna, led by a team of finance and industry experts, is building its diversified portfolio of royalty investments in scalable, best-in-class projects and companies in U.S. legal states, with a focus on California. For additional information visit www.fincannacapital.com and FinCanna's profile at www.sedar.com.
FinCanna Capital Corp.
Andriyko Herchak, CEO & Director
Investor Relations:
Arlen Hansen
Kin Communications
1-866-684-6730
Volume was more important lastly but represented Sell orders, the accumulation-distribution line is down so we are still in the distribution step, are we at the end of this distribution-downtrend step ??? only imho.
at a purchase price of $0.30 per Unit.
Do I want to look at FinCanna?
FinCanna Capital Increases Private Placement to $6.1 Million https://globenewswire.com/news-release/2018/06/29/1531535/0/en/FinCanna-Increases-Private-Placement-to-6-1-Million.html
https://plus.google.com/u/0/+WeedWarrior
Jun 28 2018 Equity Guru Article on Fincanna https://equity.guru/2018/06/28/fincanna-cali-c-shareholders-worry-california-banks/
https://plus.google.com/u/0/+WeedWarrior
Cannabis Officially Legal in Canada Starting Oct 17 2018 https://globalnews.ca/news/4285946/marijuana-legal-date-october-17-canada-trudeau-confirms/
https://plus.google.com/u/0/+WeedWarrior
we will see, I am not a soothsayer like you.
nonsense. new pp just out going thru end of june, and new filing due then as well so millions more warants upcoming.
distribution of warrants has been already done, it is already in the filings of the company. Their strike price is above the level of the pps, their expiration is in august 2018 and in 2019.
That is why I put money only if I see a stabilization of the pps after going down. For me a dip is good if he is followed by a stabilisation, just imo.
warrant dilution is huge. that's the downside to business model. upcoming fins will show it.
Buy the dips, no big money behind this yet.
did you see the news ? seems to be in good progress. one thing is good but we have to wait before to invest = the pps is going down since the beginning. we can see a good accumulation line till june but I think it will go up again.
This company is on my radar, good business model, no P and D, they build their business step by step.
FinCanna CEO Andriyko Herchak Interview by CFN https://www.nasdaq.com/press-release/cfn-exclusive-interview-with-fincanna-ceo-andriyko-herchak-20180614-00535
https://plus.google.com/u/0/+WeedWarrior
Fincanna Affiliate CTI Reaches First $1M US in Cannabis Extraction Revenue https://www.fincannacapital.com/news/2018/fincanna-flagship-investment-cti-reaches-first-1m-usd-in-cannabis-extraction-revenue-
https://plus.google.com/u/0/+WeedWarrior
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
147
|
Created
|
02/21/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |